Alnylam Pharmaceuticals, Inc. (ALNY)

224.03 -3.25 (-1.43%) USD  |  NASDAQ  |  Oct 23, 16:00
223.90 -0.13 (-0.06%) After-Hours: 20:00
More

Alnylam Pharmaceuticals Annual EPS GAAP Estimates

Annual EPS GAAP Estimates Chart

View Annual EPS GAAP Estimates for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Annual EPS GAAP Estimates Data

View and export this data back to 2024. Start Trial.
Date Value
December 31, 2028 --
December 31, 2027 --
December 31, 2026 --
Date Value
December 31, 2025 --
December 31, 2024 --

Annual EPS GAAP Estimates Range, Past 5 Years

View Annual EPS GAAP Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual EPS GAAP Estimates Benchmarks

View Annual EPS GAAP Estimates Benchmarks
Start Trial
Ionis Pharmaceuticals, Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
BridgeBio Pharma, Inc. Upgrade
Pfizer Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade